ritanserin



ritanserin


SMILES Cc1nc2sccn2c(=O)c1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1
InChIKey JUQLTPCYUFPYKE-UHFFFAOYSA-N

Chemical Properties

Hydrogen bond acceptors 5
Hydrogen bond donors 0
Rotatable bonds 5
Molecular weight (Da) 477.2

Database connections

Structure pdb 6BQH
Ligand site mutations 5-HT1A 5-HT2A 5-HT2C 5-HT6

Bioactivities

Receptor Activity Source
Protein Gene Species Family Class Type Min Avg Max Database
Receptor Activity Source
Protein Gene Species Family Class Type Min Avg Max Database

ritanserin


Drug properties

Molecular type Small molecule
Physiological/Surrogate Surrogate
Approved drug Yes

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections

Structure pdb 6BQH
Ligand site mutations 5-HT1A 5-HT2A 5-HT2C 5-HT6

Compound is not listed as a drug.